PMC:1064895 / 26989-27204 JSONTXT

{"project":"test3","denotations":[{"id":"T17207","span":{"begin":198,"end":203},"obj":"Protein"},{"id":"T17206","span":{"begin":185,"end":194},"obj":"Positive_regulation"},{"id":"T17205","span":{"begin":73,"end":78},"obj":"Protein"},{"id":"T17204","span":{"begin":67,"end":71},"obj":"Protein"},{"id":"T17203","span":{"begin":40,"end":49},"obj":"Positive_regulation"},{"id":"T17087","span":{"begin":198,"end":203},"obj":"Protein"},{"id":"T17086","span":{"begin":73,"end":78},"obj":"Protein"},{"id":"T17085","span":{"begin":67,"end":71},"obj":"Protein"}],"relations":[{"id":"R9321","pred":"themeOf","subj":"T17207","obj":"T17206"}],"text":"In view of the fact that NF-κB was also activated by anti-CD3/anti-CD28, IL-15 or mitogens in our experiments, it is most likely that the NF-κB pathway is also actively involved in the induction of IL-17 in RA PBMC."}

{"project":"BioNLP16_Messiy","denotations":[{"id":"T20159","span":{"begin":185,"end":194},"obj":"Positive_regulation"},{"id":"T20158","span":{"begin":169,"end":177},"obj":"Regulation"},{"id":"T20100","span":{"begin":198,"end":203},"obj":"Protein"},{"id":"T20099","span":{"begin":73,"end":78},"obj":"Protein"},{"id":"T20098","span":{"begin":67,"end":71},"obj":"Protein"}],"relations":[{"id":"R10633","pred":"themeOf","subj":"T20100","obj":"T20159"},{"id":"R10662","pred":"themeOf","subj":"T20159","obj":"T20158"}],"text":"In view of the fact that NF-κB was also activated by anti-CD3/anti-CD28, IL-15 or mitogens in our experiments, it is most likely that the NF-κB pathway is also actively involved in the induction of IL-17 in RA PBMC."}

{"project":"BioNLP16_DUT","denotations":[{"id":"T21976","span":{"begin":185,"end":194},"obj":"Positive_regulation"},{"id":"T21924","span":{"begin":198,"end":203},"obj":"Protein"},{"id":"T21923","span":{"begin":73,"end":78},"obj":"Protein"},{"id":"T21922","span":{"begin":67,"end":71},"obj":"Protein"}],"relations":[{"id":"R12047","pred":"themeOf","subj":"T21924","obj":"T21976"}],"text":"In view of the fact that NF-κB was also activated by anti-CD3/anti-CD28, IL-15 or mitogens in our experiments, it is most likely that the NF-κB pathway is also actively involved in the induction of IL-17 in RA PBMC."}

{"project":"biosemtest","denotations":[{"id":"T18085","span":{"begin":94,"end":102},"obj":"UMLS/C0026249"},{"id":"T18020","span":{"begin":157,"end":164},"obj":"UMLS/C1704259"},{"id":"T17834","span":{"begin":182,"end":190},"obj":"UMLS/C1314939"},{"id":"T17789","span":{"begin":182,"end":190},"obj":"UMLS/C1947935"},{"id":"T17746","span":{"begin":134,"end":140},"obj":"UMLS/C0332148"},{"id":"T17741","span":{"begin":94,"end":102},"obj":"UMLS/C0018284"},{"id":"T17979","span":{"begin":14,"end":18},"obj":"UMLS/C0449911"},{"id":"T17961","span":{"begin":110,"end":121},"obj":"UMLS/C1706386"},{"id":"T17454","span":{"begin":85,"end":90},"obj":"UMLS/C1149222"},{"id":"T17440","span":{"begin":85,"end":90},"obj":"UMLS/C0254610"},{"id":"T17423","span":{"begin":52,"end":61},"obj":"UMLS/C1879547"},{"id":"T17407","span":{"begin":85,"end":90},"obj":"UMLS/C1334105"},{"id":"T17319","span":{"begin":110,"end":121},"obj":"UMLS/C0681814"},{"id":"T17646","span":{"begin":157,"end":164},"obj":"UMLS/C1705987"},{"id":"T17620","span":{"begin":198,"end":207},"obj":"UMLS/C0205263"},{"id":"T17589","span":{"begin":198,"end":207},"obj":"UMLS/C1621983"}],"text":"In view of the fact that NF-κB was also activated by anti-CD3/anti-CD28, IL-15 or mitogens in our experiments, it is most likely that the NF-κB pathway is also actively involved in the induction of IL-17 in RA PBMC."}

{"project":"pmc-enju-pas","denotations":[{"id":"T19298","span":{"begin":210,"end":214},"obj":"NN"},{"id":"T19297","span":{"begin":207,"end":209},"obj":"NN"},{"id":"T19296","span":{"begin":204,"end":206},"obj":"IN"},{"id":"T19295","span":{"begin":198,"end":203},"obj":"NN"},{"id":"T19294","span":{"begin":195,"end":197},"obj":"IN"},{"id":"T19293","span":{"begin":185,"end":194},"obj":"NN"},{"id":"T19292","span":{"begin":181,"end":184},"obj":"DT"},{"id":"T19291","span":{"begin":178,"end":180},"obj":"IN"},{"id":"T19290","span":{"begin":169,"end":177},"obj":"VB"},{"id":"T19289","span":{"begin":160,"end":168},"obj":"RB"},{"id":"T19288","span":{"begin":155,"end":159},"obj":"RB"},{"id":"T19287","span":{"begin":152,"end":154},"obj":"VB"},{"id":"T19286","span":{"begin":144,"end":151},"obj":"NN"},{"id":"T19285","span":{"begin":138,"end":143},"obj":"NN"},{"id":"T19284","span":{"begin":134,"end":137},"obj":"DT"},{"id":"T19283","span":{"begin":129,"end":133},"obj":"IN"},{"id":"T19282","span":{"begin":122,"end":128},"obj":"JJ"},{"id":"T19281","span":{"begin":117,"end":121},"obj":"RB"},{"id":"T19280","span":{"begin":114,"end":116},"obj":"VB"},{"id":"T19279","span":{"begin":111,"end":113},"obj":"PRP"},{"id":"T19278","span":{"begin":109,"end":110},"obj":"-COMMA-"},{"id":"T19277","span":{"begin":98,"end":109},"obj":"NN"},{"id":"T19276","span":{"begin":94,"end":97},"obj":"PRP-DOLLAR-"},{"id":"T19275","span":{"begin":91,"end":93},"obj":"IN"},{"id":"T19274","span":{"begin":82,"end":90},"obj":"NN"},{"id":"T19273","span":{"begin":79,"end":81},"obj":"CC"},{"id":"T19272","span":{"begin":73,"end":78},"obj":"NN"},{"id":"T19271","span":{"begin":71,"end":72},"obj":"-COMMA-"},{"id":"T19270","span":{"begin":53,"end":71},"obj":"JJ"},{"id":"T19269","span":{"begin":50,"end":52},"obj":"IN"},{"id":"T19268","span":{"begin":40,"end":49},"obj":"VB"},{"id":"T19267","span":{"begin":35,"end":39},"obj":"RB"},{"id":"T19266","span":{"begin":31,"end":34},"obj":"VB"},{"id":"T19265","span":{"begin":25,"end":30},"obj":"NN"},{"id":"T19264","span":{"begin":20,"end":24},"obj":"IN"},{"id":"T19263","span":{"begin":15,"end":19},"obj":"NN"},{"id":"T19262","span":{"begin":11,"end":14},"obj":"DT"},{"id":"T19261","span":{"begin":8,"end":10},"obj":"IN"},{"id":"T19260","span":{"begin":3,"end":7},"obj":"NN"},{"id":"T19259","span":{"begin":0,"end":2},"obj":"IN"}],"relations":[{"id":"R10289","pred":"arg2Of","subj":"T19260","obj":"T19259"},{"id":"R10290","pred":"arg1Of","subj":"T19260","obj":"T19261"},{"id":"R10291","pred":"arg2Of","subj":"T19263","obj":"T19261"},{"id":"R10292","pred":"arg1Of","subj":"T19263","obj":"T19262"},{"id":"R10293","pred":"arg1Of","subj":"T19265","obj":"T19266"},{"id":"R10294","pred":"arg2Of","subj":"T19265","obj":"T19268"},{"id":"R10295","pred":"arg2Of","subj":"T19268","obj":"T19263"},{"id":"R10296","pred":"arg1Of","subj":"T19268","obj":"T19264"},{"id":"R10297","pred":"arg2Of","subj":"T19268","obj":"T19266"},{"id":"R10298","pred":"arg1Of","subj":"T19268","obj":"T19267"},{"id":"R10299","pred":"arg1Of","subj":"T19272","obj":"T19273"},{"id":"R10300","pred":"arg1Of","subj":"T19273","obj":"T19268"},{"id":"R10301","pred":"arg2Of","subj":"T19273","obj":"T19269"},{"id":"R10302","pred":"arg1Of","subj":"T19273","obj":"T19270"},{"id":"R10303","pred":"arg1Of","subj":"T19273","obj":"T19271"},{"id":"R10304","pred":"arg1Of","subj":"T19273","obj":"T19275"},{"id":"R10305","pred":"arg2Of","subj":"T19274","obj":"T19273"},{"id":"R10306","pred":"arg2Of","subj":"T19277","obj":"T19275"},{"id":"R10307","pred":"arg1Of","subj":"T19277","obj":"T19276"},{"id":"R10308","pred":"arg1Of","subj":"T19280","obj":"T19259"},{"id":"R10309","pred":"arg1Of","subj":"T19280","obj":"T19278"},{"id":"R10310","pred":"arg2Of","subj":"T19282","obj":"T19280"},{"id":"R10311","pred":"arg1Of","subj":"T19282","obj":"T19281"},{"id":"R10312","pred":"arg1Of","subj":"T19286","obj":"T19284"},{"id":"R10313","pred":"arg1Of","subj":"T19286","obj":"T19285"},{"id":"R10314","pred":"arg1Of","subj":"T19286","obj":"T19287"},{"id":"R10315","pred":"arg2Of","subj":"T19286","obj":"T19290"},{"id":"R10316","pred":"arg1Of","subj":"T19290","obj":"T19279"},{"id":"R10317","pred":"arg1Of","subj":"T19290","obj":"T19280"},{"id":"R10318","pred":"arg1Of","subj":"T19290","obj":"T19282"},{"id":"R10319","pred":"arg1Of","subj":"T19290","obj":"T19283"},{"id":"R10320","pred":"arg2Of","subj":"T19290","obj":"T19287"},{"id":"R10321","pred":"arg1Of","subj":"T19290","obj":"T19288"},{"id":"R10322","pred":"arg1Of","subj":"T19290","obj":"T19289"},{"id":"R10323","pred":"arg1Of","subj":"T19290","obj":"T19291"},{"id":"R10324","pred":"arg2Of","subj":"T19293","obj":"T19291"},{"id":"R10325","pred":"arg1Of","subj":"T19293","obj":"T19292"},{"id":"R10326","pred":"arg1Of","subj":"T19293","obj":"T19294"},{"id":"R10327","pred":"arg1Of","subj":"T19293","obj":"T19296"},{"id":"R10328","pred":"arg2Of","subj":"T19295","obj":"T19294"},{"id":"R10329","pred":"arg2Of","subj":"T19298","obj":"T19296"},{"id":"R10330","pred":"arg1Of","subj":"T19298","obj":"T19297"}],"namespaces":[{"prefix":"_base","uri":"http://kmcs.nii.ac.jp/enju/"}],"text":"In view of the fact that NF-κB was also activated by anti-CD3/anti-CD28, IL-15 or mitogens in our experiments, it is most likely that the NF-κB pathway is also actively involved in the induction of IL-17 in RA PBMC."}

{"project":"bionlp-st-ge-2016-test-proteins","denotations":[{"id":"T19515","span":{"begin":198,"end":203},"obj":"Protein"},{"id":"T19514","span":{"begin":73,"end":78},"obj":"Protein"},{"id":"T19513","span":{"begin":67,"end":71},"obj":"Protein"}],"namespaces":[{"prefix":"_base","uri":"http://bionlp.dbcls.jp/ontology/ge.owl#"}],"text":"In view of the fact that NF-κB was also activated by anti-CD3/anti-CD28, IL-15 or mitogens in our experiments, it is most likely that the NF-κB pathway is also actively involved in the induction of IL-17 in RA PBMC."}

{"project":"bionlp-st-ge-2016-uniprot","denotations":[{"id":"T20006","span":{"begin":67,"end":71},"obj":"http://www.uniprot.org/uniprot/P10747"},{"id":"T20001","span":{"begin":58,"end":61},"obj":"http://www.uniprot.org/uniprot/P09693"},{"id":"T19993","span":{"begin":58,"end":61},"obj":"http://www.uniprot.org/uniprot/P07766"},{"id":"T19985","span":{"begin":58,"end":61},"obj":"http://www.uniprot.org/uniprot/P04234"},{"id":"T19957","span":{"begin":198,"end":203},"obj":"http://www.uniprot.org/uniprot/Q16552"},{"id":"T19977","span":{"begin":58,"end":61},"obj":"http://www.uniprot.org/uniprot/P20963"},{"id":"T20016","span":{"begin":73,"end":78},"obj":"http://www.uniprot.org/uniprot/P40933"}],"namespaces":[{"prefix":"_base","uri":"http://www.uniprot.org/uniprot/"}],"text":"In view of the fact that NF-κB was also activated by anti-CD3/anti-CD28, IL-15 or mitogens in our experiments, it is most likely that the NF-κB pathway is also actively involved in the induction of IL-17 in RA PBMC."}

{"project":"GO-MF","denotations":[{"id":"T19580","span":{"begin":73,"end":78},"obj":"http://purl.obolibrary.org/obo/GO_0016170"},{"id":"T19550","span":{"begin":198,"end":203},"obj":"http://purl.obolibrary.org/obo/GO_0030367"}],"text":"In view of the fact that NF-κB was also activated by anti-CD3/anti-CD28, IL-15 or mitogens in our experiments, it is most likely that the NF-κB pathway is also actively involved in the induction of IL-17 in RA PBMC."}

{"project":"sentences","denotations":[{"id":"T18168","span":{"begin":0,"end":215},"obj":"Sentence"},{"id":"T190","span":{"begin":0,"end":215},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In view of the fact that NF-κB was also activated by anti-CD3/anti-CD28, IL-15 or mitogens in our experiments, it is most likely that the NF-κB pathway is also actively involved in the induction of IL-17 in RA PBMC."}

{"project":"simple1","denotations":[{"id":"T19922","span":{"begin":198,"end":203},"obj":"Protein"},{"id":"T19921","span":{"begin":73,"end":78},"obj":"Protein"},{"id":"T19920","span":{"begin":67,"end":71},"obj":"Protein"}],"text":"In view of the fact that NF-κB was also activated by anti-CD3/anti-CD28, IL-15 or mitogens in our experiments, it is most likely that the NF-κB pathway is also actively involved in the induction of IL-17 in RA PBMC."}

{"project":"DLUT931","denotations":[{"id":"T20280","span":{"begin":169,"end":177},"obj":"Regulation"},{"id":"T20279","span":{"begin":185,"end":194},"obj":"Positive_regulation"},{"id":"T20224","span":{"begin":198,"end":203},"obj":"Protein"},{"id":"T20223","span":{"begin":73,"end":78},"obj":"Protein"},{"id":"T20222","span":{"begin":67,"end":71},"obj":"Protein"}],"relations":[{"id":"R10702","pred":"themeOf","subj":"T20224","obj":"T20279"},{"id":"R10728","pred":"themeOf","subj":"T20279","obj":"T20280"}],"text":"In view of the fact that NF-κB was also activated by anti-CD3/anti-CD28, IL-15 or mitogens in our experiments, it is most likely that the NF-κB pathway is also actively involved in the induction of IL-17 in RA PBMC."}

{"project":"bionlp-st-ge-2016-test-ihmc","denotations":[{"id":"T21837","span":{"begin":178,"end":214},"obj":"Positive_regulation"},{"id":"T21836","span":{"begin":178,"end":214},"obj":"Gene_expression"},{"id":"T21795","span":{"begin":20,"end":30},"obj":"Protein"},{"id":"T21786","span":{"begin":207,"end":214},"obj":"Entity"},{"id":"T21772","span":{"begin":62,"end":71},"obj":"Protein"},{"id":"T21739","span":{"begin":134,"end":151},"obj":"Protein"},{"id":"T21712","span":{"begin":82,"end":90},"obj":"Entity"},{"id":"T21695","span":{"begin":207,"end":209},"obj":"Protein"},{"id":"T21676","span":{"begin":35,"end":61},"obj":"Protein"},{"id":"T21618","span":{"begin":73,"end":78},"obj":"Protein"},{"id":"T21651","span":{"begin":195,"end":203},"obj":"Protein"}],"relations":[{"id":"R11931","pred":"themeOf","subj":"T21651","obj":"T21836"},{"id":"R11935","pred":"themeOf","subj":"T21651","obj":"T21837"}],"text":"In view of the fact that NF-κB was also activated by anti-CD3/anti-CD28, IL-15 or mitogens in our experiments, it is most likely that the NF-κB pathway is also actively involved in the induction of IL-17 in RA PBMC."}

{"project":"bionlp-st-ge-2016-spacy-parsed","denotations":[{"id":"T21303","span":{"begin":214,"end":215},"obj":"."},{"id":"T21302","span":{"begin":210,"end":214},"obj":"NNP"},{"id":"T21301","span":{"begin":207,"end":209},"obj":"NNP"},{"id":"T21300","span":{"begin":204,"end":206},"obj":"IN"},{"id":"T21299","span":{"begin":198,"end":203},"obj":"NNP"},{"id":"T21298","span":{"begin":195,"end":197},"obj":"IN"},{"id":"T21297","span":{"begin":185,"end":194},"obj":"NN"},{"id":"T21296","span":{"begin":181,"end":184},"obj":"DT"},{"id":"T21295","span":{"begin":178,"end":180},"obj":"IN"},{"id":"T21294","span":{"begin":169,"end":177},"obj":"VBN"},{"id":"T21293","span":{"begin":160,"end":168},"obj":"RB"},{"id":"T21292","span":{"begin":155,"end":159},"obj":"RB"},{"id":"T21291","span":{"begin":152,"end":154},"obj":"VBZ"},{"id":"T21290","span":{"begin":144,"end":151},"obj":"NN"},{"id":"T21289","span":{"begin":138,"end":143},"obj":"NNP"},{"id":"T21288","span":{"begin":134,"end":137},"obj":"DT"},{"id":"T21287","span":{"begin":129,"end":133},"obj":"IN"},{"id":"T21286","span":{"begin":122,"end":128},"obj":"JJ"},{"id":"T21285","span":{"begin":117,"end":121},"obj":"RBS"},{"id":"T21284","span":{"begin":114,"end":116},"obj":"VBZ"},{"id":"T21283","span":{"begin":111,"end":113},"obj":"PRP"},{"id":"T21282","span":{"begin":109,"end":110},"obj":","},{"id":"T21281","span":{"begin":98,"end":109},"obj":"NNS"},{"id":"T21280","span":{"begin":94,"end":97},"obj":"PRP$"},{"id":"T21279","span":{"begin":91,"end":93},"obj":"IN"},{"id":"T21278","span":{"begin":82,"end":90},"obj":"NNS"},{"id":"T21277","span":{"begin":79,"end":81},"obj":"CC"},{"id":"T21276","span":{"begin":73,"end":78},"obj":"NN"},{"id":"T21275","span":{"begin":71,"end":72},"obj":","},{"id":"T21274","span":{"begin":62,"end":71},"obj":"NN"},{"id":"T21273","span":{"begin":61,"end":62},"obj":"NN"},{"id":"T21272","span":{"begin":53,"end":61},"obj":"JJ"},{"id":"T21271","span":{"begin":50,"end":52},"obj":"IN"},{"id":"T21270","span":{"begin":40,"end":49},"obj":"VBN"},{"id":"T21269","span":{"begin":35,"end":39},"obj":"RB"},{"id":"T21268","span":{"begin":31,"end":34},"obj":"VBD"},{"id":"T21267","span":{"begin":25,"end":30},"obj":"NNP"},{"id":"T21266","span":{"begin":20,"end":24},"obj":"IN"},{"id":"T21265","span":{"begin":15,"end":19},"obj":"NN"},{"id":"T21264","span":{"begin":11,"end":14},"obj":"DT"},{"id":"T21263","span":{"begin":8,"end":10},"obj":"IN"},{"id":"T21262","span":{"begin":3,"end":7},"obj":"NN"},{"id":"T21261","span":{"begin":0,"end":2},"obj":"IN"}],"relations":[{"id":"R11619","pred":"prep","subj":"T21261","obj":"T21284"},{"id":"R11620","pred":"pobj","subj":"T21262","obj":"T21261"},{"id":"R11621","pred":"prep","subj":"T21263","obj":"T21262"},{"id":"R11623","pred":"det","subj":"T21264","obj":"T21265"},{"id":"R11624","pred":"pobj","subj":"T21265","obj":"T21263"},{"id":"R11626","pred":"mark","subj":"T21266","obj":"T21270"},{"id":"R11627","pred":"nsubjpass","subj":"T21267","obj":"T21270"},{"id":"R11628","pred":"auxpass","subj":"T21268","obj":"T21270"},{"id":"R11629","pred":"advmod","subj":"T21269","obj":"T21270"},{"id":"R11630","pred":"acl","subj":"T21270","obj":"T21265"},{"id":"R11631","pred":"agent","subj":"T21271","obj":"T21270"},{"id":"R11632","pred":"amod","subj":"T21272","obj":"T21274"},{"id":"R11634","pred":"compound","subj":"T21273","obj":"T21274"},{"id":"R11635","pred":"pobj","subj":"T21274","obj":"T21271"},{"id":"R11636","pred":"punct","subj":"T21275","obj":"T21274"},{"id":"R11637","pred":"conj","subj":"T21276","obj":"T21274"},{"id":"R11639","pred":"cc","subj":"T21277","obj":"T21276"},{"id":"R11643","pred":"conj","subj":"T21278","obj":"T21276"},{"id":"R11644","pred":"prep","subj":"T21279","obj":"T21278"},{"id":"R11645","pred":"poss","subj":"T21280","obj":"T21281"},{"id":"R11646","pred":"pobj","subj":"T21281","obj":"T21279"},{"id":"R11648","pred":"punct","subj":"T21282","obj":"T21284"},{"id":"R11649","pred":"nsubj","subj":"T21283","obj":"T21284"},{"id":"R11651","pred":"ROOT","subj":"T21284","obj":"T21284"},{"id":"R11652","pred":"advmod","subj":"T21285","obj":"T21286"},{"id":"R11653","pred":"acomp","subj":"T21286","obj":"T21284"},{"id":"R11655","pred":"mark","subj":"T21287","obj":"T21294"},{"id":"R11656","pred":"det","subj":"T21288","obj":"T21290"},{"id":"R11657","pred":"compound","subj":"T21289","obj":"T21290"},{"id":"R11658","pred":"nsubjpass","subj":"T21290","obj":"T21294"},{"id":"R11660","pred":"auxpass","subj":"T21291","obj":"T21294"},{"id":"R11661","pred":"advmod","subj":"T21292","obj":"T21294"},{"id":"R11662","pred":"advmod","subj":"T21293","obj":"T21294"},{"id":"R11664","pred":"ccomp","subj":"T21294","obj":"T21286"},{"id":"R11665","pred":"prep","subj":"T21295","obj":"T21294"},{"id":"R11666","pred":"det","subj":"T21296","obj":"T21297"},{"id":"R11668","pred":"pobj","subj":"T21297","obj":"T21295"},{"id":"R11669","pred":"prep","subj":"T21298","obj":"T21297"},{"id":"R11670","pred":"pobj","subj":"T21299","obj":"T21298"},{"id":"R11672","pred":"prep","subj":"T21300","obj":"T21297"},{"id":"R11673","pred":"compound","subj":"T21301","obj":"T21302"},{"id":"R11674","pred":"pobj","subj":"T21302","obj":"T21300"},{"id":"R11676","pred":"punct","subj":"T21303","obj":"T21284"}],"text":"In view of the fact that NF-κB was also activated by anti-CD3/anti-CD28, IL-15 or mitogens in our experiments, it is most likely that the NF-κB pathway is also actively involved in the induction of IL-17 in RA PBMC."}

{"project":"bionlp-st-ge-2016-test-tees","denotations":[{"id":"T19768","span":{"begin":169,"end":177},"obj":"Regulation"},{"id":"T19767","span":{"begin":169,"end":177},"obj":"Regulation"},{"id":"T19766","span":{"begin":185,"end":194},"obj":"Positive_regulation"},{"id":"T19765","span":{"begin":185,"end":194},"obj":"Positive_regulation"},{"id":"T19764","span":{"begin":40,"end":49},"obj":"Positive_regulation"},{"id":"T19763","span":{"begin":40,"end":49},"obj":"Positive_regulation"},{"id":"T19762","span":{"begin":40,"end":49},"obj":"Positive_regulation"},{"id":"T19761","span":{"begin":207,"end":214},"obj":"Protein"},{"id":"T19760","span":{"begin":198,"end":203},"obj":"Protein"},{"id":"T19759","span":{"begin":138,"end":143},"obj":"Protein"},{"id":"T19758","span":{"begin":73,"end":78},"obj":"Protein"},{"id":"T19757","span":{"begin":62,"end":71},"obj":"Protein"},{"id":"T19756","span":{"begin":53,"end":61},"obj":"Protein"},{"id":"T19755","span":{"begin":25,"end":30},"obj":"Protein"}],"relations":[{"id":"R10556","pred":"themeOf","subj":"T19755","obj":"T19762"},{"id":"R10557","pred":"themeOf","subj":"T19755","obj":"T19763"},{"id":"R10558","pred":"themeOf","subj":"T19755","obj":"T19764"},{"id":"R10559","pred":"causeOf","subj":"T19756","obj":"T19762"},{"id":"R10560","pred":"causeOf","subj":"T19757","obj":"T19763"},{"id":"R10561","pred":"causeOf","subj":"T19758","obj":"T19764"},{"id":"R10562","pred":"causeOf","subj":"T19759","obj":"T19767"},{"id":"R10563","pred":"causeOf","subj":"T19759","obj":"T19768"},{"id":"R10564","pred":"themeOf","subj":"T19760","obj":"T19765"},{"id":"R10565","pred":"themeOf","subj":"T19761","obj":"T19766"},{"id":"R10566","pred":"themeOf","subj":"T19765","obj":"T19767"},{"id":"R10567","pred":"themeOf","subj":"T19766","obj":"T19768"}],"text":"In view of the fact that NF-κB was also activated by anti-CD3/anti-CD28, IL-15 or mitogens in our experiments, it is most likely that the NF-κB pathway is also actively involved in the induction of IL-17 in RA PBMC."}

{"project":"testone","denotations":[{"id":"T17019","span":{"begin":185,"end":194},"obj":"Positive_regulation"},{"id":"T17018","span":{"begin":169,"end":177},"obj":"Regulation"},{"id":"T16958","span":{"begin":198,"end":203},"obj":"Protein"},{"id":"T16957","span":{"begin":73,"end":78},"obj":"Protein"},{"id":"T16956","span":{"begin":67,"end":71},"obj":"Protein"}],"relations":[{"id":"R9233","pred":"themeOf","subj":"T16958","obj":"T17019"},{"id":"R9263","pred":"themeOf","subj":"T17019","obj":"T17018"}],"text":"In view of the fact that NF-κB was also activated by anti-CD3/anti-CD28, IL-15 or mitogens in our experiments, it is most likely that the NF-κB pathway is also actively involved in the induction of IL-17 in RA PBMC."}